Atypical hyperplasia
| Atypical hyperplasia | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Often asymptomatic, may be detected during mammography or biopsy |
| Complications | Increased risk of breast cancer |
| Onset | Typically diagnosed in postmenopausal women |
| Duration | Chronic |
| Types | N/A |
| Causes | Unknown, but associated with hormonal factors |
| Risks | Family history of breast cancer, hormone replacement therapy |
| Diagnosis | Biopsy, histopathology |
| Differential diagnosis | Ductal carcinoma in situ, Lobular carcinoma in situ |
| Prevention | Regular screening, lifestyle modification |
| Treatment | Surgical excision, chemoprevention with tamoxifen or raloxifene |
| Medication | N/A |
| Prognosis | Good with treatment, but requires regular monitoring |
| Frequency | Affects approximately 5-10% of women undergoing breast biopsies |
| Deaths | N/A |
Atypical Hyperplasia is a medical condition characterized by abnormal growth of cells in the breast or endometrium. It is considered a precancerous condition and is associated with an increased risk of developing breast cancer or endometrial cancer.
Definition[edit]
Atypical Hyperplasia refers to the presence of abnormal cells in the breast or endometrium. The term 'atypical' denotes that these cells differ from normal cells in their size, shape, or organization, while 'hyperplasia' indicates an increase in the number of cells. This condition is not cancer, but it can be a forerunner to the onset of breast cancer or endometrial cancer.
Types[edit]
There are two types of Atypical Hyperplasia: Atypical Ductal Hyperplasia (ADH) and Atypical Lobular Hyperplasia (ALH). Both types occur in the breast tissue, but they are distinguished by the location of the abnormal cells. In ADH, the abnormal cells are in the lining of a duct, while in ALH, they are in the lobules.
Risk Factors[edit]
Several risk factors are associated with Atypical Hyperplasia. These include age, family history of breast or endometrial cancer, never having been pregnant, late menopause, and hormone therapy, particularly when estrogen is given without progesterone.
Diagnosis[edit]
Atypical Hyperplasia is usually diagnosed through a biopsy, which involves removing a small sample of tissue for examination under a microscope. The biopsy can be performed using a fine needle, a core needle, or through a surgical procedure.
Treatment[edit]
The treatment for Atypical Hyperplasia depends on the individual patient's risk factors and the extent of the condition. Options may include careful monitoring, medication, or surgery.
Prognosis[edit]
While Atypical Hyperplasia increases the risk of developing breast or endometrial cancer, it does not guarantee that cancer will develop. Regular check-ups and preventive measures can help manage the risk.
See Also[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian